A detailed history of Suvretta Capital Management, LLC transactions in Molecular Partners Ag stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 400,000 shares of MOLN stock, worth $2.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
400,000
Previous 400,000 -0.0%
Holding current value
$2.8 Million
Previous $1.67 Million 0.48%
% of portfolio
0.07%
Previous 0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

BUY
$19.25 - $21.01 $7.7 Million - $8.4 Million
400,000 New
400,000 $8.2 Million

Others Institutions Holding MOLN

About MOLECULAR PARTNERS AG


  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $228M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.